Literature DB >> 21874321

The importance of correction for tissue fraction effects in lung PET: preliminary findings.

Tryphon Lambrou1, Ashley M Groves, Kjell Erlandsson, Nick Screaton, Raymondo Endozo, Thida Win, Joanna C Porter, Brian F Hutton.   

Abstract

PURPOSE: It has recently been recognized that PET/CT may play a role in diffuse parenchymal lung disease. However, interpretation can be confounded due to the variability in lung density both within and between individuals. To address this issue a novel correction method is proposed.
METHODS: A CT scan acquired during shallow breathing is registered to a PET study and smoothed so as to match the PET resolution. This is used to derive voxel-based tissue fraction correction factors for the individual. The method was evaluated in a lung phantom study in which the lung was simulated by a Styrofoam/water mixture. The method was further evaluated using (18)F-FDG in 12 subjects free from pulmonary disease where ranges before and after correction were considered.
RESULTS: Correction resulted in similar activity concentrations for the lung and background regions, consistent with the experimental phantom set-up. Correction resulted in reduced inter- and intrasubject variability in the estimated SUV. The possible application of the method was further demonstrated in five subjects with interstitial lung changes where increased SUV was demonstrated. Single study pre- and post-treatment studies were also analysed to further illustrate the utility of the method.
CONCLUSION: The proposed tissue fraction correction method is a promising technique to account for variability of density in interpreting lung PET studies.

Entities:  

Mesh:

Year:  2011        PMID: 21874321     DOI: 10.1007/s00259-011-1906-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  25 in total

1.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.

Authors:  Thomas Beyer; Gerald Antoch; Todd Blodgett; Lutz F Freudenberg; Tim Akhurst; Stephan Mueller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-12       Impact factor: 9.236

2.  Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT.

Authors:  Medhat M Osman; Christian Cohade; Yuji Nakamoto; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-21       Impact factor: 9.236

3.  Analytical positron range modelling in heterogeneous media for PET Monte Carlo simulation.

Authors:  Wencke Lehnert; Marie-Claude Gregoire; Anthonin Reilhac; Steven R Meikle
Journal:  Phys Med Biol       Date:  2011-05-10       Impact factor: 3.609

Review 4.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  Pulmonary tissue attenuation with computed tomography: comparison of inspiration and expiration scans.

Authors:  P J Robinson; L Kreel
Journal:  J Comput Assist Tomogr       Date:  1979-12       Impact factor: 1.826

6.  Differences in CT density between dependent and nondependent portions of the lung: influence of lung volume.

Authors:  J A Verschakelen; L Van fraeyenhoven; G Laureys; M Demedts; A L Baert
Journal:  AJR Am J Roentgenol       Date:  1993-10       Impact factor: 3.959

7.  Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.

Authors:  Thida Win; Nicholas J Screaton; Joanna Porter; Raymondo Endozo; Damian Wild; Irfan Kayani; John Dickson; Robert I Shortman; Jean C Reubi; Peter J Ell; Ashley M Groves
Journal:  Mol Imaging       Date:  2012-04       Impact factor: 4.488

8.  Clinical significance of histological classification of idiopathic interstitial pneumonia.

Authors:  K R Flaherty; G B Toews; W D Travis; T V Colby; E A Kazerooni; B H Gross; A Jain; R L Strawderman; R Paine; A Flint; J P Lynch; F J Martinez
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

9.  Positron emission tomography in interstitial lung disease.

Authors:  Samir Nusair; Rina Rubinstein; Nanette M Freedman; Gail Amir; Naama R Bogot; Uzi Izhar; Raphael Breuer
Journal:  Respirology       Date:  2007-11       Impact factor: 6.424

10.  Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PET.

Authors:  Jules Lavalaye; Jan C Grutters; Ewoudt M W van de Garde; Monique M C van Buul; Jules M M van den Bosch; Albert D Windhorst; Fred J Verzijlbergen
Journal:  Mol Imaging Biol       Date:  2008-07-30       Impact factor: 3.488

View more
  23 in total

1.  [18F]Fluorocholine and [18F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM.

Authors:  Taylor R Kavanagh; William J Mischler; Eline E Verwer; You Feng; Kazue Takahashi; Shuyan Wang; Timothy M Shoup; Ramesh Neelamegam; Jing Yang; Nicolas J Guehl; Chongzhao Ran; Walter Massefski; Ye Cui; Souheil El-Chemaly; Peter M Sadow; William M Oldham; Marie F Kijewski; Georges El Fakhri; Marc D Normandin; Carmen Priolo
Journal:  Clin Cancer Res       Date:  2018-07-27       Impact factor: 12.531

2.  Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.

Authors:  Pauline Désogère; Luis F Tapias; Lida P Hariri; Nicholas J Rotile; Tyson A Rietz; Clemens K Probst; Francesco Blasi; Helen Day; Mari Mino-Kenudson; Paul Weinreb; Shelia M Violette; Bryan C Fuchs; Andrew M Tager; Michael Lanuti; Peter Caravan
Journal:  Sci Transl Med       Date:  2017-04-05       Impact factor: 17.956

3.  18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.

Authors:  Thida Win; Tryphon Lambrou; Brian F Hutton; Irfan Kayani; Nicholas J Screaton; Joanna C Porter; Toby M Maher; Raymondo Endozo; Robert I Shortman; Pauline Lukey; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-30       Impact factor: 9.236

4.  Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.

Authors:  Jazmin Schwartz; Milan Grkovski; Andreas Rimner; Heiko Schöder; Pat B Zanzonico; Sean D Carlin; Kevin D Staton; John L Humm; Sadek A Nehmeh
Journal:  J Nucl Med       Date:  2017-02-23       Impact factor: 10.057

Review 5.  Imaging the acute respiratory distress syndrome: past, present and future.

Authors:  Laurent Bitker; Daniel Talmor; Jean-Christophe Richard
Journal:  Intensive Care Med       Date:  2022-07-14       Impact factor: 41.787

6.  PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.

Authors:  Andréa L Bastos; Gilda A Ferreira; Marcelo Mamede; Eliane V Mancuzo; Mauro M Teixeira; Flávia P S T Santos; Cid S Ferreira; Ricardo A Correa
Journal:  J Bras Pneumol       Date:  2022-06-06       Impact factor: 2.800

Review 7.  Quantification of Lung PET Images: Challenges and Opportunities.

Authors:  Delphine L Chen; Joseph Cheriyan; Edwin R Chilvers; Gourab Choudhury; Christopher Coello; Martin Connell; Marie Fisk; Ashley M Groves; Roger N Gunn; Beverley F Holman; Brian F Hutton; Sarah Lee; William MacNee; Divya Mohan; David Parr; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Edwin J R van Beek; Laurence Vass; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

8.  Quantification of the α v β 6 Integrin by PET/CT Imaging in the Lungs of Patients After SARS-CoV2 Infection and Comparison to Fibrotic Lungs.

Authors:  Pauline T Lukey; Frederick J Wilson
Journal:  J Nucl Med       Date:  2021-04-09       Impact factor: 11.082

9.  Consensus Recommendations on the Use of 18F-FDG PET/CT in Lung Disease.

Authors:  Delphine L Chen; Safia Ballout; Laigao Chen; Joseph Cheriyan; Gourab Choudhury; Ana M Denis-Bacelar; Elise Emond; Kjell Erlandsson; Marie Fisk; Francesco Fraioli; Ashley M Groves; Roger N Gunn; Jun Hatazawa; Beverley F Holman; Brian F Hutton; Hidehiro Iida; Sarah Lee; William MacNee; Keiko Matsunaga; Divya Mohan; David Parr; Alaleh Rashidnasab; Gaia Rizzo; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Nicola Tregay; Edwin J R van Beek; Laurence Vass; Marcos F Vidal Melo; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson; Tilo Winkler
Journal:  J Nucl Med       Date:  2020-09-18       Impact factor: 11.082

10.  Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers.

Authors:  Liza Botros; Samara M A Jansen; Ali Ashek; Onno A Spruijt; Jelco Tramper; Anton V Noordegraaf; Jurjan Aman; Hans Harms; Frances S de Man; Marc C Huisman; Lan Zhao; Harm J Bogaard
Journal:  Pulm Circ       Date:  2021-06-30       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.